Is Flow Cytometric Immunophenotyping Useful for Predicting Acute Myeloid Leukemia Prognosis?

Creative Commons License

ÜSKÜDAR TEKE H., OĞUZ DAVUTOĞLU N., GÜNDÜZ E., ANDIÇ N., BAL C., DURAK ARAS B.

ISTANBUL MEDICAL JOURNAL, cilt.18, sa.4, ss.200-204, 2017 (ESCI) identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 18 Sayı: 4
  • Basım Tarihi: 2017
  • Doi Numarası: 10.5152/imj.2017.15045
  • Dergi Adı: ISTANBUL MEDICAL JOURNAL
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.200-204
  • Eskişehir Osmangazi Üniversitesi Adresli: Evet

Özet

Introduction: Acute myeloid leukemia (AML) is an aggressive clonal myeloid neoplasm that causes the accumulation of myeloblasts in blood and bone marrow. This study aimed to determine immunophenotypic characteristics and their prognostic value in patients with AML, to compare the results of patients with the literature and to reveal regional differences.